# Cabaletta Bio, Inc.: filings

CABA · Nasdaq · CIK 1759138 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/caba.md) · [Financials](/companies/caba/financials.md) · [Filings](/companies/caba/filings.md) · [Insiders](/companies/caba/insiders.md)

## Reports and events: 137 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 120, 8-K 92, SC 13G/A 37, SCHEDULE 13G/A 22, 10-Q 21, SC 13G 20, 3 17, S-8 9, 144 8, CORRESP 8, 10-K 7, 424B5 7, DEF 14A 7, DEFA14A 6, SCHEDULE 13G 6, EFFECT 5, SC 13D/A 5, UPLOAD 5, ARS 4, S-3 3, 8-K/A 2, D 2, DRS/A 2, DRSLTR 2, PRE 14A 2, SEC STAFF LETTER 2, 424B4 1, 4/A 1, 5 1, 8-A12B 1, CERT 1, DRS 1, FWP 1, POS AM 1, POSASR 1, S-1 1, S-1/A 1, S-1MEF 1, S-3ASR 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-14 | 08:00 ET | [8-K](/filings/0001759138-26-000041.md) | 8.01 Other events | 0001759138-26-000041 |
| 2026-08-13 | 07:34 ET | [10-Q](/filings/0001759138-26-000039.md) | Quarterly report, period 2026-06-30 | 0001759138-26-000039 |
| 2026-08-13 | 07:32 ET | [8-K](/filings/0001759138-26-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759138-26-000038 |
| 2026-06-11 | 07:01 ET | [8-K](/filings/0001759138-26-000033.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001759138-26-000033 |
| 2026-06-03 | 07:02 ET | [8-K](/filings/0001759138-26-000030.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001759138-26-000030 |
| 2026-05-14 | 07:08 ET | [10-Q](/filings/0001759138-26-000026.md) | Quarterly report, period 2026-03-31 | 0001759138-26-000026 |
| 2026-05-14 | 07:06 ET | [8-K](/filings/0001759138-26-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759138-26-000025 |
| 2026-05-14 | 07:02 ET | [8-K](/filings/0001759138-26-000024.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001759138-26-000024 |
| 2026-05-04 | 06:40 ET | [8-K](/filings/0001193125-26-202446.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-202446 |
| 2026-05-04 | 06:02 ET | [8-K](/filings/0001193125-26-202389.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-202389 |
| 2026-04-28 | 07:31 ET | [DEF 14A](/filings/0001193125-26-183557.md) | Proxy statement, period 2026-06-09 | 0001193125-26-183557 |
| 2026-04-20 | 07:01 ET | [8-K](/filings/0001759138-26-000016.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001759138-26-000016 |
| 2026-03-23 | 07:36 ET | [10-K](/filings/0001759138-26-000011.md) | Annual report, period 2025-12-31 | 0001759138-26-000011 |
| 2026-03-23 | 07:32 ET | [8-K](/filings/0001759138-26-000010.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759138-26-000010 |
| 2026-01-12 | 08:02 ET | [8-K](/filings/0001193125-26-009819.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-26-009819 |
| 2025-11-10 | 07:37 ET | [10-Q](/filings/0001193125-25-273280.md) | Quarterly report, period 2025-09-30 | 0001193125-25-273280 |
| 2025-11-10 | 07:33 ET | [8-K](/filings/0001193125-25-273272.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-273272 |
| 2025-10-29 | 07:01 ET | [8-K](/filings/0001193125-25-254610.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-254610 |
| 2025-10-27 | 07:02 ET | [8-K](/filings/0001193125-25-250676.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-250676 |
| 2025-10-09 | 12:03 ET | [8-K](/filings/0001193125-25-235533.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-235533 |
| 2025-09-03 | 06:03 ET | [8-K](/filings/0001759138-25-000007.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759138-25-000007 |
| 2025-08-07 | 07:41 ET | [10-Q](/filings/0000950170-25-104573.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104573 |
| 2025-08-07 | 07:37 ET | [8-K](/filings/0000950170-25-104570.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104570 |
| 2025-06-12 | 06:05 ET | [8-K](/filings/0001193125-25-139517.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-139517 |
| 2025-06-11 | 06:11 ET | [8-K](/filings/0001193125-25-138737.md) | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-138737 |
| 2025-06-10 | 17:49 ET | [8-K](/filings/0001193125-25-137954.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-137954 |
| 2025-05-19 | 17:22 ET | [8-K](/filings/0000950170-25-074589.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-074589 |
| 2025-05-15 | 07:10 ET | [10-Q](/filings/0000950170-25-071971.md) | Quarterly report, period 2025-03-31 | 0000950170-25-071971 |
| 2025-05-15 | 07:05 ET | [8-K](/filings/0000950170-25-071966.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-071966 |
| 2025-05-13 | 08:00 ET | [DEF 14A](/filings/0001193125-25-118330.md) | Proxy statement, period 2025-06-09 | 0001193125-25-118330 |
| 2025-03-31 | 07:16 ET | [10-K](/filings/0000950170-25-047201.md) | Annual report, period 2024-12-31 | 0000950170-25-047201 |
| 2025-03-31 | 07:03 ET | [8-K](/filings/0000950170-25-047196.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-047196 |
| 2025-02-18 | 13:03 ET | [8-K/A](/filings/0001193125-25-028420.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028420 |
| 2025-02-18 | 07:05 ET | [8-K](/filings/0001193125-25-028143.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028143 |
| 2025-01-13 | 08:10 ET | [8-K](/filings/0001193125-25-005016.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-005016 |
| 2024-11-18 | 07:05 ET | [8-K](/filings/0001193125-24-260425.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-260425 |
| 2024-11-14 | 07:14 ET | [10-Q](/filings/0000950170-24-126733.md) | Quarterly report, period 2024-09-30 | 0000950170-24-126733 |
| 2024-11-14 | 07:07 ET | [8-K](/filings/0000950170-24-126731.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-126731 |
| 2024-10-07 | 06:06 ET | [8-K](/filings/0001193125-24-233294.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-233294 |
| 2024-09-30 | 16:30 ET | [8-K](/filings/0000950170-24-110389.md) | 1.01 Entry into a material agreement | 0000950170-24-110389 |
| 2024-08-08 | 07:25 ET | [10-Q](/filings/0000950170-24-093325.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093325 |
| 2024-08-08 | 07:07 ET | [8-K](/filings/0001193125-24-196467.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-196467 |
| 2024-06-14 | 06:06 ET | [8-K](/filings/0001193125-24-161089.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-161089 |
| 2024-06-04 | 16:32 ET | [8-K](/filings/0001193125-24-154309.md) | 5.07 Shareholder vote results | 0001193125-24-154309 |
| 2024-05-15 | 07:53 ET | [10-Q](/filings/0000950170-24-060045.md) | Quarterly report, period 2024-03-31 | 0000950170-24-060045 |
| 2024-05-15 | 07:04 ET | [8-K](/filings/0001193125-24-138874.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-138874 |
| 2024-04-23 | 07:00 ET | [DEF 14A](/filings/0001193125-24-105870.md) | Proxy statement, period 2024-06-03 | 0001193125-24-105870 |
| 2024-03-21 | 07:24 ET | [10-K](/filings/0000950170-24-034422.md) | Annual report, period 2023-12-31 | 0000950170-24-034422 |
| 2024-03-21 | 07:12 ET | [8-K](/filings/0001193125-24-073294.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-073294 |
| 2024-03-20 | 07:11 ET | [8-K](/filings/0001193125-24-072048.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-072048 |

Page 1 of 3. [Older](/companies/caba/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 11:27 ET. No prices; not investment advice.